These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7202502)

  • 1. Evidence that noradrenaline modulates the increase in striatal dopamine metabolism induced by muscarinic receptor stimulation.
    Weinstock M; Zavadil AP; Muth EA; Crowley WR; O'Donohue TL; Jacobowitz DM; Kopin IJ
    Eur J Pharmacol; 1980 Dec; 68(4):427-35. PubMed ID: 7202502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of d- and l-propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain.
    Weinstock M; Zavadil AP; Kopin IJ
    Eur J Pharmacol; 1979 Nov; 59(3-4):187-93. PubMed ID: 527644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
    Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
    Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1975 Aug; 33(1):31-40. PubMed ID: 126169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F; Suddath RL; Wyatt RJ
    Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M; Mizobe F; Yamamoto T; Kato T
    Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in the turnover of brain dopamine by stimulation of muscarinic receptors outside the dopamine nerve terminals.
    Andén NE; Wachtel H
    J Pharm Pharmacol; 1977 Jul; 29(7):435-7. PubMed ID: 19584
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
    Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
    Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine.
    Weinstock M; Zavadil AP; Kopin IJ
    Monogr Neural Sci; 1980; 7():138-45. PubMed ID: 7231435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats.
    Wang JQ; McGinty JF
    Brain Res; 1997 Feb; 748(1-2):62-70. PubMed ID: 9067445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of drugs on the formation of homovanillic acid in the rat retina.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):175-8. PubMed ID: 11106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs.
    Westerink BH; Lejeune B; Korf J; Van Praag HM
    Eur J Pharmacol; 1977 Mar; 42(2):179-90. PubMed ID: 844497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.
    Nose T; Takemoto H
    Eur J Pharmacol; 1974 Jan; 25(1):51-5. PubMed ID: 4435012
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to biochemical evaluation of brain dopamine metabolism.
    Kopin IJ; White JH; Bankiewicz K
    Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.
    De Klippel N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 1993 Dec; 630(1-2):57-64. PubMed ID: 8118706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.